How to Find and Prospect AI Leaders in Healthcare & Life Sciences (2026)

Quick Answer: The fastest way to find AI leaders in healthcare and life sciences is Origami — describe your ideal customer profile in one prompt, and its AI agent searches the live web, chains enrichment, and delivers a verified contact list with names, emails, phone numbers, and company details. It works even when titles are buried or when targets aren’t on LinkedIn.

You sell a platform that accelerates drug discovery with machine learning. Your champion is a VP of AI at a mid-sized biotech, but that role rarely shows up on ZoomInfo. A rep texts you: “I’ve searched ‘Head of AI’ on Apollo and got nothing. These companies list ‘Director of Computational Biology’ or ‘SVP, Digital Transformation’ — I can’t find these people.” That’s the reality of prospecting AI pioneers in a regulated, title-opaque industry. The person you need exists, but the databases haven’t caught up yet.

Why traditional B2B databases miss healthcare AI leaders

Most contact databases are built for enterprise sales motions — they index standard functional titles like VP of Sales or CMO. In healthcare and life sciences, AI leadership often sits under R&D, clinical informatics, or digital health. A Director of Translational Informatics at a cancer center may run a team of 20 ML engineers, but because “AI” isn’t in their title, they’re invisible to static contact databases that rely on keyword matching. One sales leader told me, “Our CRM is full of CTOs who aren’t the real buyers; the AI budget sits with a lab director who’s never on LinkedIn.” That’s the data gap.

The other problem is tenure and role velocity. A Head of Data Science at a biotech might stay for 18 months, then move to a health system. ZoomInfo and Apollo refresh their data on a periodic cycle; by the time a rep gets the contact, the person has already left. In a fast-moving niche where heads of AI turn over every year, freshness isn’t a nice-to-have — it’s the difference between reaching the actual decision-maker and burning your domain on dead emails. A live web search that checks company pages, conference speaker lists, and PubMed author affiliations surfaces current role data that static databases simply don’t have yet.

How to structure a prospecting prompt that actually returns AI leaders in life sciences

Stop searching by title alone. The AI leaders you need are described by their work, not their org chart. A better approach: describe the problems they solve and the context in which they operate.

For example, instead of typing “head of AI pharma,” write: Find senior-level AI, machine learning, or computational biology leaders at pharma and biotech companies with 200+ employees in the US, who are involved in drug discovery R&D, and who have spoken at conferences like ISMB or Bio-IT World. This prompt tells the AI agent to look across multiple signals — job titles, company descriptions, investor presentations, conference pages — and cross-reference them. Origami handles this natively because it searches the live web and chains data sources without manual workflow building, unlike Clay which requires you to construct multi-step waterfall enrichment tables.

You can also target by technology stack. Many life sciences AI teams use specific infrastructure: ONT sequencing data, AWS HealthLake, Nvidia Clara, or open-source frameworks like ChemBERTa. If you sell into that stack, include it in your prompt. For example: Find AI leaders at CROs and biotech companies that mention deploying Nvidia Clara or MONAI in their job postings, conference talks, or technical blogs in the last 12 months. This yields a list of people whose teams actually use the tools you support, not just anyone with an AI title.

A quick answer: How do I find AI decision-makers whose titles don’t include “AI” or “machine learning”? Describe their output — they publish in computational biology journals, they lead digital pathology initiatives, they present at Radiological Society meetings. The AI agent then crawls those sources, extracts names and affiliations, and enriches with contact data. One salesperson told us, “I spent hours manually cross-referencing PubMed authors with LinkedIn, then guessed emails. With Origami, I got it in ten minutes.”

The “I can’t find them on LinkedIn” problem — and how to solve it

Repeatedly in sales conversations, prospects told us: “Most of the people I’m looking at… LinkedIn is not where they live.” This isn’t a hypothetical; it’s one of the most common pain points in healthcare and life sciences sales. Many senior AI leaders at hospitals, academic medical centers, and smaller biotechs have minimal LinkedIn presence. Their work appears in grants, FDA advisory committee minutes, clinical trial registrations, and niche conference programs.

Origami addresses this by searching beyond LinkedIn. It crawls government databases, license boards, PubMed, conference sites, and company newsrooms — wherever the target’s actual name and affiliation appear. For a health system CIO or a chief medical information officer who doesn’t maintain a LinkedIn profile, their contact information often sits on a hospital board page or a county health department directory. A static contact database won’t index that; a live web agent will.

What about data privacy and compliance? Many of these sources are public — state medical board directories, certified EHR vendor listings, federal research grant databases. A live web search that respects robots.txt and uses public information sidesteps the compliance headaches that come with proprietary data scraping. For sales teams selling into heavily regulated environments (HIPAA, GDPR), using publicly available signals is a safer, more defensible approach.

Tools that can actually find healthcare AI leaders (and which ones don’t)

Not every prospecting tool is built for this vertical. Here’s a comparison of what works, what struggles, and where the real gaps are.

Tool	Free Plan	Starting Price	Best For	Main Limitation
Origami	Yes (1,000 credits, no credit card)	Free, then $29/mo	Finding AI leaders by describing their work and context; live web search adapts to any title or source	Not an outreach tool; you export the list and use your own sequencer
Apollo	Yes (900 credits/year)	$49/mo (annual)	Generic B2B prospecting when titles match standard filters; sequences	Contact-centric database struggles with niche titles and non-LinkedIn roles
ZoomInfo	No	~$15,000/year	Large-scale enterprise targeting with standard firmographics	Expensive, static database; misses roles not in standard corporate hierarchies
Clay	Yes (500 actions/mo)	$0, then $167/mo	Power users who build complex enrichment workflows from multiple sources	Requires manual workflow construction; steep learning curve for non-technical users
Hunter.io	Yes (50 credits/mo)	$34/mo	Finding email addresses for a known company domain	No AI-powered search; you must know the company and domain first

If you need to prospect AI leaders today without building Clay tables or paying a five-figure ZoomInfo contract, start with the free plan on Origami. Describe your ICP, get a verified list, and push it into your existing outreach tool. One sales engineer at a genomics platform told us, “We fed it ‘AI leads in biotech who use AWS and have published on transformer models,’ and it returned a list of 80 names with valid emails. I never would’ve found those manually.”

After you have the list: what makes an AI leader in healthcare respond?

Prospecting AI leaders means you must understand their incentives. In pharma, AI investment is often tied to specific milestones: a new drug target, a faster clinical trial readout, or a regulatory submission. Messaging that references a recent breakthrough — e.g., “I saw your team’s paper in Nature Medicine on graph neural networks for rare disease indication” — immediately signals you’ve done your homework. AI leaders in this space are inundated with generic “AI consulting” pitches; they delete anything that doesn’t acknowledge their specific domain.

A practical tip: before you send a single email, spend five minutes on the target’s most recent conference talk or preprint. Use that to craft a first line that could only have been written about them. Origami can surface these data points (publications, presentations, recent news) as enrichment columns. Then take that enriched list into your outreach tool of choice — Outreach, Salesloft, HubSpot, or even a manual Gmail sequence.

How do I personalize outreach to AI leaders at scale? Don’t automate the personalization; leverage a tool that gives you the raw material. For each contact, gather one specific detail (a paper, a talk, a grant) that you can paraphrase into your opener. That detail doesn’t have to be profound — just relevant. A sales rep targeting bioinformatics leaders might say, “I saw your Lightning Talk at BioIT — the part about integrating real-world data with genomic features in GNNs resonated.” That line takes ten seconds to write once you have the detail, and it dramatically outperforms any generic template.

Common mistakes when prospecting AI leaders in life sciences

Mistake 1: Targeting the wrong persona. Many reps go after the CTO or CDO, but the actual AI buying power often sits with a VP of R&D Informatics or a Director of Computational Science. Role titles don’t always match responsibility. Prompt for function, not just title.

Mistake 2: Ignoring the academic side. A significant number of AI leaders in life sciences hold dual appointments at universities and hospitals. Their most visible email address might be an .edu, not a corporate domain. A live web search can find both.

Mistake 3: Using stale data. A contact who was at Regeneron six months ago may now lead AI at a health system. Static databases often retain the old affiliation, leading to bounces and degraded sender reputation. Freshness is critical.

Mistake 4: Neglecting technographic signals. The tools a team uses — Python, R, TensorFlow, AWS SageMaker, Databricks — are strong indicators of AI maturity. Include these in your search criteria to avoid the “AI washing” that happens when companies re-label analytics groups as AI.